Mirror‐Image Organometallic Osmium Arene Iminopyridine Halido Complexes Exhibit Similar Potent Anticancer Activity

Four chiral Os^II arene anticancer complexes have been isolated by fractional crystallization. The two iodido complexes, (S_Os,S_C)‐[Os(η⁶‐p‐cym)(ImpyMe)I]PF₆ (complex 2 , (S)‐ImpyMe: N‐(2‐pyridylmethylene)‐(S)‐1‐phenylethylamine) and (R_Os,R_C)‐[Os(η⁶‐p‐cym)(ImpyMe)I]PF₆ (complex 4 , (R)‐ImpyMe: N‐(2‐pyridylmethylene)‐(R)‐1‐phenylethylamine), showed higher anticancer activity (lower IC₅₀ values) towards A2780 human ovarian cancer cells than cisplatin and were more active than the two chlorido derivatives, (S_Os,S_C)‐[Os(η⁶‐p‐cym)(ImpyMe)Cl]PF₆, 1 , and (R_Os,R_C)‐[Os(η⁶‐p‐cym)(ImpyMe)Cl]PF₆, 3 . The two iodido complexes were evaluated in the National Cancer Institute 60‐cell‐line screen, by using the COMPARE algorithm. This showed that the two potent iodido complexes, 2 (NSC: D‐758116/1) and 4 (NSC: D‐758118/1), share surprisingly similar cancer cell selectivity patterns with the anti‐microtubule drug, vinblastine sulfate. However, no direct effect on tubulin polymerization was found for 2 and 4 , an observation that appears to indicate a novel mechanism of action. In addition, complexes 2 and 4 demonstrated potential as transfer‐hydrogenation catalysts for imine reduction.